Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
06/2000
06/07/2000CN1053115C Medicine for acute diarrhea of baby and prepn. thereof
06/07/2000CN1053107C Method for preparing vigour strenthening instant powder and Yuan strengthening tablet by using ginseng and scutellaria root
06/07/2000CN1053105C Plaster for activating collaterals to relieve pain
06/07/2000CN1053101C Method for prepn. of heterovesicular liposomes
06/07/2000CA2291565A1 Process for mixing or dispersing liquids
06/06/2000US6072100 Extrudable compositions for topical or transdermal drug delivery
06/06/2000US6071974 Limpid parenteral solution of 2,6-diisoprophylphenol as an anaesthetic drug and 2.5-di-O-methyl-1.4;3.6-dianhydro-D-glucitol as a solvent for making clear I. V. formulation
06/06/2000US6071964 Decreased gastrointestinal irritation, increased bioavailability
06/06/2000US6071959 For relieving pain of lower gastrointestinal tract by rectal or oral administration of a complex of amide-type local anaesthetic and polyacrylate with carrier, diluent and/or excipient
06/06/2000US6071958 Ophthalmic carrier solution
06/06/2000US6071952 Stabilized injectable pharmaceutical compositions containing taxoid anti-neoplastic agents
06/06/2000US6071948 Treatment of diseases caused by excessive blood vessel growth
06/06/2000US6071942 Elevation of circulating blood histamine levels
06/06/2000US6071924 Method of preventing proliferation of retinal pigment epithelium by retinoic acid receptor agonists
06/06/2000US6071904 Process for manufacturing ophthalmic suspensions
06/06/2000US6071896 Suppression of thromboxane levels by percutaneous administration of aspirin
06/06/2000US6071890 Organ-specific targeting of cationic amphiphile/DNA complexes for gene therapy
06/06/2000US6071539 Effervescent granules and methods for their preparation
06/06/2000US6071538 Oral delivery composition comprising supramolecular complex
06/06/2000US6071536 Carboxymethylcellulose calcium, croscarmellose sodium, and/or polyvinylpyrrolidone; stabilization
06/06/2000US6071535 Lipid vesicles formed with alkylammonium fatty acid salts
06/06/2000US6071534 Removal of solvent from water in oil emulsion containing hydrochloric acid; arginine, lysine, histidine, and/or pyridine hydrochloride(s)
06/06/2000US6071533 Mixing with hydrophilic polymer to increase shelf life
06/06/2000US6071532 Synthesis of glycophospholipid and peptide-phospholipid conjugates and uses thereof
06/06/2000US6071531 Transdermal patch and method for administering 17-deacetyl norgestimate alone or in combination with an estrogen
06/06/2000US6071530 Dispensing solution of biodegradable, water insoluble, thermoplastic resin with biocompatible solvent onto support; coagulation
06/06/2000US6071524 Unsaturated fatty acid monoglyceride, phytanetriol, and surfactant; cosmetics
06/06/2000US6071523 Oral administering from squeezable container; storage stability, heat resistance; drug delivery
06/06/2000US6071512 Administering replication defective recombinant retrovirion with gene operable linked to control sequence
06/06/2000US6071510 Modified amino acids and compositions comprising the same for delivering active agents
06/06/2000US6071508 Preparation of formulations for electrotransport drug delivery
06/06/2000US6071500 Xylitol, calcium hydroxide, vitamin b, potassium, citric acid, and magnesium stearate
06/06/2000US6071498 Inhaler for powdered medicaments
06/06/2000US6071497 Microparticles for lung delivery comprising diketopiperazine
06/06/2000US6071495 Targeted gas and gaseous precursor-filled liposomes
06/06/2000US6071494 Lipid, protein or polymer and a gas or gaseous precursor, in combination with a renal vasodilator.
06/06/2000CA2206233C Combination dosage form comprising cetirizine and pseudoephedrine
06/06/2000CA2132547C Vaccines containing non-ionic surfactant vesicles
06/06/2000CA2101466C Taste-masking composition of bitter pharmaceutical agents
06/06/2000CA2060182C Resuspendable coated magnetic particles and stable magnetic particle suspensions
06/06/2000CA2058975C Antiinflammatory gel preparation
06/03/2000CA2290847A1 Cosmetic or dermatological composition comprising at least one alkynyl carbamate and at least one polyol
06/02/2000WO2000031123A2 Retro-inversion peptides that target gastro-intestinal tract transport receptors and use thereof
06/02/2000WO2000031098A1 Injectable anthelmintic formulation
06/02/2000WO2000031058A1 Novel agarofuan derivatives, their preparation, pharmaceutical composition containing them and their use as medicine
06/02/2000WO2000031044A1 Iminoguanidine derivatives, preparation method, use as medicines
06/02/2000WO2000030694A1 Coating useful as a dispenser of an active ingredient on dressings and bandages
06/02/2000WO2000030691A1 Improved uncomplexed cyclodextrin compositions for odor control
06/02/2000WO2000030685A1 Pharmaceutical composition comprising bupropion hydrochloride
06/02/2000WO2000030667A2 Compositions and methods using lactadherin or variants thereof
06/02/2000WO2000030660A2 Hyperforin as cytostatic agent and hyperforin ointment or cream as application form
06/02/2000WO2000030657A1 A process for producing an iron-dextran compound
06/02/2000WO2000030654A1 Anti-asthmatic combinations comprising surface active phospholipids
06/02/2000WO2000030650A1 Desmethylolanzapine compositions and methods
06/02/2000WO2000030648A1 2-hydroxymethylolanzapine compositions and methods
06/02/2000WO2000030647A1 Compositions comprising cefuroxime axetil
06/02/2000WO2000030641A1 Nicotine-containing pharmaceutical compositions giving a rapid transmucosal absorption
06/02/2000WO2000030635A1 Composition and use of rar antagonists for promoting chondrogenesis
06/02/2000WO2000030626A2 Methods and kits for treating vulvovaginal candidiasis with miconazole nitrate
06/02/2000WO2000030622A2 Utilisation of dialkylfumarates for treating host-versus-graft reactions and auto-immune diseases
06/02/2000WO2000030621A1 Pressure-sensitive adhesive gel composition for iontophoresis and apparatus therefor
06/02/2000WO2000030620A1 Solid lipidic nanospheres suitable to a fast internalization into cells
06/02/2000WO2000030619A1 Self-emulsifying ibuprofen solution and soft gelatin capsule for use therewith
06/02/2000WO2000030618A1 Particles based on polyamino-acid(s) and methods for preparing same
06/02/2000WO2000030617A1 Taste masking rapid release coating system
06/02/2000WO2000030616A1 Dispersible phospholipid stabilized microparticles
06/02/2000WO2000030615A1 Method of preparing stable suspensions of insoluble microparticles
06/02/2000WO2000030614A1 A process for producing particles with a converted amorphous and/or meta-stable crystalline region into crystalline state
06/02/2000WO2000030613A1 New process
06/02/2000WO2000030612A1 A method of producing drug particles
06/02/2000WO2000030611A2 Pharmaceutical preparation
06/02/2000WO2000030609A1 Aqueous ophthalmic formulations comprising chitosan
06/02/2000WO2000030608A1 Pressurised metered dose inhalers (mdi)
06/02/2000WO2000030607A1 PHARMACEUTICAL AEROSOL COMPOSITION CONTAINING HFA 227 AND HFA 134a
06/02/2000WO2000030606A1 Method for regulating a chemical valve
06/02/2000WO2000030605A2 Method for producing medicaments from plant extracts, in a solid form of administration
06/02/2000WO2000030602A1 Oil bodies as topical delivery vehicles for active agents
06/02/2000WO2000030586A1 Method of producing solid dosage forms
06/02/2000WO2000030578A1 Enzymatic treatment and prevention of hypertrophic skin
06/02/2000WO2000030449A1 Antiparasitic formulations
06/02/2000WO2000030444A1 Cationic liposomes for gene transfer
06/02/2000WO2000013710A3 Hydrogel compositions for the controlled release administration of growth factors
06/02/2000WO2000013680A3 Filamentous amorphous carbohydrate compositions and therapeutic delivery vehicles comprising them
06/02/2000WO2000010605A3 Preventives or remedies for eye circulatory failure
06/02/2000WO2000010535A3 Exactly divisible tablet
06/02/2000WO2000010525A3 Fish gelatinous composition for use as an ingredient in tablets
06/02/2000WO2000009179A3 Methods, instruments and materials for chondrocyte cell transplantation
06/02/2000WO2000009084A3 Biodegradable microparticles gel composition
06/02/2000WO2000004874A3 Soft gelatine capsules containing olive oil
06/02/2000CA2698376A1 Pressurised metered dose inhalers (mdi)
06/02/2000CA2353071A1 Oil bodies as topical delivery vehicles for active agents
06/02/2000CA2352611A1 2-hydroxymethylolanzapine compositions and methods
06/02/2000CA2352462A1 Adhesive gel composition for iontophoresis and devices therefor
06/02/2000CA2352458A1 Compositions and methods using lactadherin or variants thereof
06/02/2000CA2351718A1 Desmethylolanzapine compositions and methods
06/02/2000CA2350594A1 Coating useful as a dispenser of an active ingredient on dressings and bandages
06/02/2000CA2349555A1 Composition and use of rar antagonists for promoting chondrogenesis
06/02/2000CA2349290A1 Retro-inversion peptides that target gastro-intestinal tract transport receptors and use thereof
06/02/2000CA2348876A1 Compositions comprising cefuroxime axetil
06/02/2000CA2332882A1 A process for producing an iron-dextran compound
1 ... 2476 2477 2478 2479 2480 2481 2482 2483 2484 2485 2486 2487 2488 2489 2490 2491 2492 2493 2494 2495 2496 ... 2991